Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2017-06-26 2017-03-14
Drug Identification Number 02284391 02284391
Brand name SANDOZ AMLODIPINE SANDOZ AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-14 2017-03-14
Estimated end date 2017-04-07 2017-04-30
Actual end date 2017-05-22
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments